Clinical Trials Browser

Phase 3 × OTHER × PE regimen × Clear all

NCT03100955 2017-04-04

A Study of Standard Treatment +/- Apatinib in Extensive Stage Small Cell Lung Cancer

Phase 3 Unknown

Progression Free Survival